Case Confirmed: A Public Health Podcast Series Case Confirmed

Case closed! Learn about the "Behind the Scenes" of your favorite episodes! Meera, Dina, and Vijeta have a nostalgic and fun conversation about the making of Case Confirmed and reveal tips for other podcasters.

Thank you to everyone who contributed to the success of our 20 episode podcast series!

In the second episode of this two part special episode, Dina interviews Dr. Rachel Robitz on the mental health impact of human trafficking on survivors. Dr. Robitz is the director of the Family Medicine/Psychiatry residency program at UC Davis. In this episode, Dr. Robitz also delves into the historical context around human trafficking in the US.

Originally envisioned as a 20 episode podcast series, we are completing the podcast with a 2-part special episode on human trafficking.

In Part 1, Vijeta interviews Dr. Hanni Stoklosa of HEAL Trafficking. As an emergency medicine physician, she discusses why human trafficking should be viewed through a public health lens. She discusses her own experiences in the ER and the various touchpoints that trafficking survivors have with the healthcare system.

Join us as Case Confirmed explores why a paradigm expansion is necessary, and why human trafficking is a public health issue.

In this episode, Case Confirmed interviews Andrew Cross, engineer and CEO of Everwell Health. We talk about tuberculosis (a bacterial infection of the lungs)and how Everwell Health is helping patients adhere to the TB treatment protocol. TB treatment involves a long-term antibiotic regimen under the observation of a healthcare provider, which can make adherence challenging. Andrew talks about some of Everwell Health's innovations, including 99DOTS. To learn more, visit 99dots.org.

Meera asks Dr. Jagpreet Chhatwal about his COVID-19 simulator tool, which uses mathematical modeling to forecast the spread of COVID-19. In this episode, he also gives great career advice to public health students about their future careers.

Dr. Chhatwal is the Associate Director of the MGH Institute for Technology Assessment and an Assistant Professor at Harvard Medical School.

Microfluidics is a new frontier in science with the potential to vastly transform healthcare. Check out this Case Confirmed interview where Meera talks with Dr. Katharine Elvira, chemist and Canada Research Chair for New Materials and Techniques in Health Applications, and learn more about this disruptive and innovative field. Potential applications include drug discovery, cancer research, rapid diagnostics, and more.